Maravai Lifesciences Holdings (MRVI) Other Non-Current Assets (2020 - 2026)

Maravai Lifesciences Holdings (MRVI) recorded quarterly Other Non-Current Assets of $40.2 million in Q1 2026, down 3.92% quarter-over-quarter from $41.9 million in Q4 2025, and down 30.13% on a YoY basis from $57.6 million in Q1 2025.

Maravai Lifesciences Holdings (MRVI) Other Non-Current Assets (2020 - 2026) Analysis & Trends

Maravai Lifesciences Holdings' Other Non-Current Assets history runs 7 years deep, the most recent figure standing at $40.2 million for Q1 2026.

  • In Q1 2026, Other Non-Current Assets fell 30.13% year-over-year to $40.2 million; the TTM figure through Mar 2026 stood at $40.2 million (down 30.13% YoY), while the FY2025 annual figure was $41.9 million, down 29.96% from the prior year.
  • Other Non-Current Assets was $40.2 million for Q1 2026 at Maravai Lifesciences Holdings, down from $41.9 million in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $127.0 million in Q1 2023 to a low of $40.2 million in Q1 2026.
  • Historically, Other Non-Current Assets has averaged $71.9 million across 5 years, with a median of $64.2 million in 2022.
  • The sharpest annual moves came in 2022 and 2024: Other Non-Current Assets surged 2028.57% in 2022, then plunged 40.98% in 2024.
  • A 5-year view of Other Non-Current Assets shows it stood at $115.6 million in 2022, then sank by 32.85% to $77.6 million in 2023, then dropped by 22.97% to $59.8 million in 2024, then retreated by 29.96% to $41.9 million in 2025, then declined by 3.92% to $40.2 million in 2026.
  • The last three Other Non-Current Assets figures came in at $40.2 million (Q1 2026), $41.9 million (Q4 2025), and $49.4 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Alterity Therapeutics 788,338.31 Bn 788,338.28 Bn - -
2 Belite Bio 56,560.00 Bn 56,560.00 Bn - 289.41 Mn
3 Quantum Biopharma 17,329.30 Bn 17,329.30 Bn - -
4 Legend Biotech 3,341.00 Bn 3,340.71 Bn 242.10 Mn 12.40 Mn
5 Akari Therapeutics 1,727.91 Bn 1,727.91 Bn - 60,000.00
6 Evaxion A 1,536.68 Bn 1,536.67 Bn - -
7 Psyence Biomedical 238.34 Bn 238.33 Bn - -
8 Vertex Pharmaceuticals 113.42 Bn 106.17 Bn 2.59 Bn 1.26 Bn
9 Abivax 95.45 Bn 95.45 Bn - -
10 Maravai Lifesciences Holdings 747.50 Mn 739.10 Mn 33.70 Mn 40.24 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 40.24 Mn
Dec 31, 2025 41.88 Mn
Sep 30, 2025 49.40 Mn
Jun 30, 2025 51.98 Mn
Mar 31, 2025 57.58 Mn
Dec 31, 2024 59.79 Mn
Sep 30, 2024 60.91 Mn
Jun 30, 2024 63.47 Mn
Mar 31, 2024 74.98 Mn
Dec 31, 2023 77.62 Mn
Sep 30, 2023 85.58 Mn
Jun 30, 2023 92.74 Mn
Mar 31, 2023 127.04 Mn
Dec 31, 2022 115.59 Mn
Sep 30, 2022 87.40 Mn
Jun 30, 2022 72.42 Mn
Mar 31, 2022 64.24 Mn
Dec 31, 2021 53.45 Mn
Sep 30, 2021 4.11 Mn
Jun 30, 2021 4.03 Mn